6-Month outcomes of tricuspid valve reconstruction for patients with severe tricuspid regurgitation G Nickenig, M Weber, R Schueler, J Hausleiter, M Näbauer, ... Journal of the American College of Cardiology 73 (15), 1905-1915, 2019 | 206 | 2019 |
Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation S Kodali, RT Hahn, MF Eleid, R Kipperman, R Smith, DS Lim, WA Gray, ... Journal of the American College of Cardiology 77 (4), 345-356, 2021 | 179 | 2021 |
Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP study DS Lim, S Kar, K Spargias, RM Kipperman, WW O’Neill, MKC Ng, NP Fam, ... Cardiovascular Interventions 12 (14), 1369-1378, 2019 | 165 | 2019 |
Evaluation of root canal debridement of human molars using the GentleWave system B Molina, G Glickman, P Vandrangi, M Khakpour Journal of endodontics 41 (10), 1701-1705, 2015 | 134 | 2015 |
Early feasibility study of cardioband tricuspid system for functional tricuspid regurgitation: 30-day outcomes CJ Davidson, DS Lim, RL Smith, SK Kodali, RM Kipperman, MF Eleid, ... Cardiovascular Interventions 14 (1), 41-50, 2021 | 69 | 2021 |
Apical pressure created during irrigation with the GentleWave™ system compared to conventional syringe irrigation M Haapasalo, YA Shen, Z Wang, E Park, A Curtis, P Patel, P Vandrangi Clinical Oral Investigations 20, 1525-1534, 2016 | 67 | 2016 |
Effectiveness of the GentleWave system in removing separated instruments P Wohlgemuth, D Cuocolo, P Vandrangi, A Sigurdsson Journal of endodontics 41 (11), 1895-1898, 2015 | 57 | 2015 |
Comparative endothelial cell response on topographically patterned titanium and silicon substrates with micrometer to sub-micrometer feature sizes P Vandrangi, SC Gott, R Kozaka, VGJ Rodgers, MP Rao PloS one 9 (10), e111465, 2014 | 46 | 2014 |
Evaluating penetration depth of treatment fluids into dentinal tubules using the GentleWave system P Vandrangi Dentistry 6 (366), 2161-1122.1000366, 2016 | 34 | 2016 |
Multisonic ultracleaning in molars with the GentleWave system P Vandrangi, B Basrani Oral Health, 72-86, 2015 | 24 | 2015 |
Microfluidic space-domain time-resolved emission spectroscopy of terbium (III) and europium (III) chelates with pyridine-2, 6-dicarboxylate V Nuñez, S Upadhyayula, B Millare, JM Larsen, A Hadian, S Shin, ... Analytical chemistry 85 (9), 4567-4577, 2013 | 19 | 2013 |
Flow-dependent mass transfer may trigger endothelial signaling cascades P Vandrangi, M Sosa, JYJ Shyy, VGJ Rodgers PloS one 7 (4), e35260, 2012 | 13 | 2012 |
Electrostatic properties of confluent Caco‐2 cell layer correlates to their microvilli growth and determines underlying transcellular flow P Vandrangi, DD Lo, R Kozaka, N Ozaki, N Carvajal, VGJ Rodgers Biotechnology and Bioengineering 110 (10), 2742-2748, 2013 | 9 | 2013 |
Novel in situ normal streaming potential device for characterizing electrostatic properties of confluent cells P Vandrangi, P Jreij, TE Rajapaksa, N Bansal, DD Lo, VGJ Rodgers Review of Scientific Instruments 83 (7), 2012 | 7 | 2012 |
Endothelial Behavior and Signaling on Micro and Submicro-Patterned Titanium P Vandrangi, S Gott, R Kozaka, MP Rao, VG Rodgers Circulation 128 (suppl_22), A18077-A18077, 2013 | 2 | 2013 |
Comparative endothelial cell adhesion, proliferation, and morphology on micro-and nanopatterned titanium and silicon P Vandrangi, SC Gott, VGJ Rodgers, MP Rao Submitted, 2013 | 1 | 2013 |
Vascular Biotransport Considerations in Signaling Cascades P Vandrangi UC Riverside, 2012 | 1 | 2012 |
Erratum:“Novel in situ normal streaming potential device for characterizing electrostatic properties of confluent cells”[Rev. Sci. Instrum. 83, 074302 (2012)] P Vandrangi, P Jreij, TE Rajapaksa, N Bansal, DD Lo, VGJ Rodgers Review of Scientific Instruments 83 (8), 2012 | | 2012 |
Mass transfer is significant factor in vascular intima signaling‐its relevance to AMPK P Vandrangi, W Sun, JJY Shyy, VGJ Rodgers The FASEB Journal 24, 644.10-644.10, 2010 | | 2010 |
Feedback Effects of Extracellular Matrix Composition on AMPK Signaling Pathway: Pathway to Novel Drug Therapeutics Targeting Atherosclerosis P Vandrangi, JYJ Shyy, VGJ Rodgers | | |